Table 1.
Preoperative patient characteristics
| Characteristic | SP group (n=30) | MP group (n=26) | P |
|---|---|---|---|
| Age (year), median (IQR) | 64.5 (60.0–69.0) | 66.5 (61.0–69.3) | 0.542 |
| BMI (kg m−2), median (IQR) | 23.9 (21.7–25.3) | 23.7 (21.9–25.5) | 0.783 |
| Prior abdominal surgery, n (%) | 6 (20.0) | 5 (19.2) | 0.942 |
| PSA (ng ml−1), median (IQR) | 9.0 (7.9–9.8) | 9.4 (8.7–10.8) | 0.304 |
| cT stage, n (%) | 0.979 | ||
| cT1c | 16 (53.3) | 14 (53.8) | |
| cT2a | 10 (33.3) | 9 (34.6) | |
| cT2b | 4 (13.3) | 3 (11.5) | |
| Biopsy ISUP grade, n (%) | 0.799 | ||
| Grade group 1 | 21 (70.0) | 19 (73.1) | |
| Grade group 2 | 3 (10.0) | 3 (11.5) | |
| Grade group 3 | 6 (20.0) | 4 (15.4) | |
| D’Amico risk classification, n (%) | 0.757 | ||
| Low-risk | 22 (73.3) | 20 (76.9) | |
| Medium-risk | 8 (26.7) | 6 (23.1) | |
| IIEF-5 score, n (%) | 0.774 | ||
| >21 | 15 (50.0) | 12 (46.2) | |
| ≤21 | 15 (50.0) | 14 (53.8) |
IQR: interquartile range; BMI: body mass index; PSA: prostate-specific antigen; IIEF-5: International Index of Erectile Function; SP: single-port; MP: multiport; ISUP: International Society of Urological Pathology